A typical FDA-approved regimen for pernicious anemia includes: 100 g IM/SC daily for 67 days Then every other day for 7 doses Then every 34 days for 23 weeks Followed by 100 g monthly for life Schedule follow-up and monitor progress Potassium levels should be monitored during the first 48 hours of treatment, as rapid red blood cell production may lead to hypokalemia and, rarely, sudden death
The high NAD+ base carries a concentrated MOTS-c and 5-Amino-1MQ pairing, making it primarily a concentrated MOTS-c / 5-Amino-1MQ blend on an NAD+ foundation
External resources NCBI Nursing Skills - Administration of Parenteral Medications PubMed Central - Efficacy and Safety of Retatrutide: Systematic Review and Meta-Analysis In case I do not see you, good afternoon, good evening, and good night
extreme tiredness (fatigue) shortness of breath chest pain or tightness problems with memory and concentration (brain fog) difficulty sleeping (insomnia) heart palpitations dizziness pins and needles joint pain depression and anxiety tinnitus, earaches feeling sick, diarrhoea, stomach aches, loss of appetite a high temperature, cough, headaches, sore throat, changes to sense of smell or taste rashes Ah
